Jeff Schaffnit: The Power of Community in Rare Blood Disorders
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
”This week, I had the privilege of attending the National Bleeding Disorders Foundation (NBDF) Annual Meeting. As always, it’s incredibly inspiring to spend time with the bleeding disorders community and hear directly from the people at the heart of everything we do.
I’m grateful to the patients, caregivers, healthcare professionals, and advocates who shared their perspectives and reminded us why listening matters. Those insights help shape how we think about the future and strengthen our commitment to helping advance research and innovation for the rare blood disorders community.
Thank you to National Bleeding Disorders Foundation for bringing the community together and creating space for these important conversations. I look forward to continuing to work alongside our partners as Sanofi continues to chase the miracles of science for people living with rare blood disorders.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments